Novalgen_logo_on_white.jpg
NovalGen appoints Dr Michael Owen and Mr Scott Clark to the Board of Directors
09 janv. 2023 07h00 HE | NovalGen Ltd.
LONDON, Jan. 09, 2023 (GLOBE NEWSWIRE) -- NovalGen Ltd (“NovalGen”), a biopharmaceutical company developing breakthrough cancer therapies, alongside a disruptive auto-regulation platform, today...